Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Samyang Biopharmaceuticals Corporation.
Recruitment status was  Recruiting
Information provided by:
Samyang Biopharmaceuticals Corporation Identifier:
First received: April 5, 2010
Last updated: April 25, 2010
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given